Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors

Author(s): Evelyne Delfourne.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 10 , 2012

Become EABM
Become Reviewer


Cancer cells are able to elaborate enzymatic mechanisms allowing tumors to resist or escape imune rejection. Among the enzymes involved, indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme that initiates the first and rate-limiting step of tryptophan breakdown along the kynurenine pathway, has emerged as a promising molecular target for the development of new immunotherapeutic anticancer agents. This review summarizes the synthesis and IDO activities of the different classes of marine and other inhibitors reported so far.

Keywords: Indoleamine 2, 3-dioxygenase, IDO inhibitors, marine natural compounds.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [988 - 996]
Pages: 9
DOI: 10.2174/138955712802762374
Price: $58

Article Metrics

PDF: 29